Workflow
Sentire思腾®腔镜手术机器人
icon
Search documents
快讯|全球首个机器人4S店将随世界机器人大会亮相亦庄,宇树科技推出新款四足机器狗 Unitree A2,四川机器人训练场启用
机器人大讲堂· 2025-08-08 14:14
Group 1 - The world's first robot 4S store will open in Yizhuang on August 8, coinciding with the 2025 World Robot Conference, attracting industry attention [1][3] - The intelligent robot-themed restaurant in Beijing's Economic and Technological Development Zone has begun operations, featuring humanoid robots and immersive dining experiences [3][4] Group 2 - Unitree Technology has launched a new quadruped robot dog, Unitree A2, weighing 37 kg with a maximum running speed of 5 m/s and a load capacity of 30 kg [6][7] - The A2 can navigate complex terrains and has a range of 20 km when unloaded, showcasing advanced mobility and sensing capabilities [6][7] Group 3 - Hong Kong Chinese University and Conostech have developed the world's first multifunctional automated surgical robot platform, achieving a significant breakthrough in autonomous surgery [9][10] - The Sentire laparoscopic surgical robot has received approval from the National Medical Products Administration and is advancing towards global certification [9][10] Group 4 - A new robot training center has been established in Sichuan, focusing on practical applications and enhancing the cognitive abilities of domestic robots [12][13] - The training center simulates real operational scenarios, providing a testing and training environment for various functional robots [12][13] Group 5 - Shenzhen Woan Robotics has launched the world's first "human-machine combat level" AI tennis robot, Acemate, which raised over 16.5 million yuan on Kickstarter, exceeding its crowdfunding goal by 76 times [16][17] - The Acemate robot features advanced visual perception and intelligent gameplay, filling a gap in competitive tennis training technology [16][17]
美团王兴,中国具身智能第一投资人
量子位· 2025-07-14 00:46
Core Viewpoint - The article highlights the aggressive investment strategy of Meituan, led by founder Wang Xing, in the field of embodied intelligence and robotics, positioning him as a key player in this emerging sector [2][10][9]. Group 1: Investment Activities - Meituan has made significant investments in two embodied intelligence companies, Shizhi Hang and Xinghai Tu, within a short span of July 2023, with total financing exceeding $100 million [4][5]. - In 2023, Wang Xing's funds have made a total of eight investments in seven companies related to embodied intelligence [8]. - Meituan's investment activities in embodied intelligence have been consistent, with a total of six investments made in the first half of 2023 alone [6]. Group 2: Notable Companies and Financing - Xinghai Tu completed A4 and A5 rounds of financing, raising over $100 million, with a post-financing valuation exceeding 3 times its valuation at the beginning of the year [14]. - Shizhi Hang achieved a financing of $122 million in its angel round, with Meituan leading the investment [16]. - Other notable companies include Kangnuo Siten, which raised 800 million yuan, and Ziyuan Robotics, which completed several rounds of financing, with Meituan participating in multiple rounds [18][20]. Group 3: Strategic Shift and Future Outlook - Meituan's investment strategy has evolved from focusing on consumer-related projects to prioritizing hard technology, particularly in robotics and AI, reflecting a broader strategic shift [39][48]. - The establishment of the Meituan Robotics Research Institute in Shenzhen marks a commitment to advancing key technologies in drones, autonomous driving, and embodied intelligence [40][41]. - Wang Xing's vision encompasses a future where robotics serves as a foundational infrastructure, bridging the digital and physical worlds [54][62].
康诺思腾完成超5亿元C轮融资,自主研发的腔镜手术机器人已获批准上市
IPO早知道· 2025-01-13 03:55
2024年是康诺思腾的商业化元年。 本文为IPO早知道原创 作者|Stone Jin 的初心,经过五年的努力,我们成功实现'自主研发、自主制造',并 已 获得中国国家药品监督管理 局的认可,也获得越来越多客户与伙伴的认可。我们团队将沿着创新的道路,让高品质的手术机器人 产品和技术,以可负担的价格,服务全球各地有需要的人。 未来,我们将继续专注于技术创新,深 入拓展全球市场、推进海外认证,携手更多合作伙伴,共同为智慧医疗行业创造价值,为人类更美好 的生活作出贡献。 " 殷拓集团(EQT)私募资本亚洲咨询团队合伙人何淑韵和萧宇成 表示: "在全球范围内,迫切需要让 更多患者能够获得高质量的机器人辅助手术医疗服务,然而,鲜有企业能达到机器人辅助手术所要求 的安全性、精准性以及严谨性。康诺思腾作为在这一领域的领军者,致力于提升医疗机器人技术的可 及性。 殷拓集团很自豪能够通过运用我们在医疗、科技以及生命科学领域的深厚专业知识来支持康 诺思腾,助力其为全球患者提供创新且可及的高品质手术机器人。" 启明创投主管合伙人胡旭波 表示: "手术机器人的发展和临床应用正在持续产生更好的治疗和临床 效果。自启明创投投资康诺思腾以来 ...